Rallybio Corp. (RLYB)
16.69
-0.10
(-0.60%)
USD |
NASDAQ |
Sep 01, 15:42
Rallybio Cash from Operations (Annual) : -29.81M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -29.81M |
| December 31, 2024 | -49.28M |
| December 31, 2023 | -60.26M |
| December 31, 2022 | -57.28M |
| Date | Value |
|---|---|
| December 31, 2021 | -45.53M |
| December 31, 2020 | -22.04M |
| December 31, 2019 | -15.03M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Q32 Bio, Inc. | -33.54M |
| Beam Therapeutics, Inc. | -345.10M |
| C4 Therapeutics, Inc. | -98.69M |
| Cullinan Therapeutics, Inc. | -175.75M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |